A Phase 1a/1b Open-Label Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of BBO-8520 in Subjects with Advanced KRASG12C Mutant Non-Small Cell Lung Cancer

Brief Summary

Type:
Lung Cancers

Study Type:
Treatment

Phase:
I

ClinicalTrials.gov Identifier:
NCT06343402

Study #:
STUDY00160304

Start Date:
Jul 10, 2024

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT06343402

View Complete Trial Details & Eligibility at ClinicalTrials.gov